XML 22 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2016   15,476,379    
Beginning Balance at Dec. 31, 2016 $ 391,547 $ 156,041 $ 249,415 $ (13,909)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net Income 10,076   10,076  
Other comprehensive income, net of tax (29)     (29)
Stock-based compensation expense 366 $ 366    
Exercise of stock options and issuance of vested share awards, net of repurchase for tax withholdings and tax benefit (shares)   31,646    
Exercise of stock options and issuance of vested share awards, net of repurchase for tax withholdings (552) $ (552)    
Cash dividends declared ($0.23 and $0.25 per share (3,581)   (3,581)  
Ending Balance (in shares) at Mar. 31, 2017   15,508,025    
Ending Balance at Mar. 31, 2017 397,827 $ 155,855 255,910 (13,938)
Beginning Balance (in shares) at Dec. 31, 2017   15,524,704    
Beginning Balance at Dec. 31, 2017 403,413 $ 156,904 266,723 (20,214)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net Income 12,820      
Other comprehensive income, net of tax (8,234)     (8,234)
Stock-based compensation expense 431 $ 431    
Exercise of stock options and issuance of vested share awards, net of repurchase for tax withholdings and tax benefit (shares)   41,164    
Exercise of stock options and issuance of vested share awards, net of repurchase for tax withholdings (475) $ (475)    
Cash dividends declared ($0.23 and $0.25 per share (3,900)   (3,900)  
Ending Balance (in shares) at Mar. 31, 2018   15,565,868.000    
Ending Balance at Mar. 31, 2018 $ 404,055 $ 156,860 275,841 (28,646)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cumulative-effect adjustment (Note 2)     $ 198 $ (198)